Eicosapentaenoic acid (EPA) formulations
US10039734B2 · kind B2 · utility
1Cited by
90References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 21, 2017 |
| Grant date | Aug 7, 2018 |
| Priority date | — |
| Expiry date | Apr 21, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any docosahexaenoic acid (DHA) or esterified fatty acids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.